[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0210028A - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
BR0210028A
BR0210028A BR0210028-2A BR0210028A BR0210028A BR 0210028 A BR0210028 A BR 0210028A BR 0210028 A BR0210028 A BR 0210028A BR 0210028 A BR0210028 A BR 0210028A
Authority
BR
Brazil
Prior art keywords
antibacterial agents
formula
compounds
preparation
useful
Prior art date
Application number
BR0210028-2A
Other languages
Portuguese (pt)
Inventor
Edmund Lee Ellsworth
Howard Daniel Hollis Showalter
Sharon Anne Powell
Joseph Peter Sanchez
James Alan Kerschen
Michael Andrew Stier
Tuan Phong Tran
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0210028A publication Critical patent/BR0210028A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"AGENTES ANTIBACTERIANOS". A presente invenção provê compostos da fórmula (I) em que R~ 1~-R~ 6~ e J e K têm quaisquer dos valores definidos no relatório descritivo e sal farmaceuticamente aceitável dos mesmos que são úteis como agentes antibacterianos. São também reveladas composições farmacêuticas que compreendem um ou mais compostos da fórmula I, processos para a preparação dos compostos da fórmula I e intermediários úteis para a preparação de compostos da fórmula I."ANTIBACTERIAL AGENTS". The present invention provides compounds of formula (I) wherein R 1 -R 6 and J and K have any of the values set forth in the specification and pharmaceutically acceptable salt thereof which are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for the preparation of compounds of formula I and intermediates useful for the preparation of compounds of formula I.

BR0210028-2A 2001-06-19 2002-05-13 Antibacterial agents BR0210028A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29924901P 2001-06-19 2001-06-19
PCT/IB2002/001768 WO2002102793A2 (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents

Publications (1)

Publication Number Publication Date
BR0210028A true BR0210028A (en) 2004-06-22

Family

ID=23153973

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210028-2A BR0210028A (en) 2001-06-19 2002-05-13 Antibacterial agents

Country Status (13)

Country Link
EP (1) EP1401830A2 (en)
JP (1) JP2005501021A (en)
AU (1) AU2002302894A1 (en)
BR (1) BR0210028A (en)
CA (1) CA2446963A1 (en)
DO (1) DOP2002000422A (en)
GT (1) GT200200104A (en)
HN (1) HN2002000150A (en)
MX (1) MXPA03009894A (en)
PA (1) PA8548401A1 (en)
PE (1) PE20030272A1 (en)
SV (1) SV2003001089A (en)
WO (1) WO2002102793A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026154A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
WO2005049605A1 (en) * 2003-11-18 2005-06-02 Warner-Lambert Company Llc Antibacterial aminoquinazolidinedione derivatives
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9090568B2 (en) 2011-03-14 2015-07-28 Impact Therapeutics, Inc. Quinazolinediones and their use
TWI527800B (en) 2011-04-01 2016-04-01 南京英派藥業有限公司 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
LT3495367T (en) 2012-06-13 2021-02-25 Incyte Holdings Corporation Substituted tricyclic compounds as fgfr inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
SI2986610T1 (en) 2013-04-19 2018-04-30 Incyte Holdings Corporation Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
SG10201913036RA (en) 2015-02-20 2020-02-27 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
MA41551A (en) 2015-02-20 2017-12-26 Incyte Corp BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
CL2015003780A1 (en) 2015-12-30 2016-09-16 Univ Chile Pyrimido-isoquinolin-quinone derivative compounds, their salts, isomers, acceptable pharmaceutical tautomers; farm compositions; preparation procedure; and its use in the treatment of multiresistant bacterial and bacterial diseases.
AR111960A1 (en) 2017-05-26 2019-09-04 Incyte Corp CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION
US10815249B2 (en) 2018-02-16 2020-10-27 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
EP3788046A1 (en) 2018-05-04 2021-03-10 Incyte Corporation Salts of an fgfr inhibitor
WO2019213544A2 (en) 2018-05-04 2019-11-07 Incyte Corporation Solid forms of an fgfr inhibitor and processes for preparing the same
CN111620866A (en) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 Cis-7, 7-difluoro-hexahydro-1H pyrrolo [3,4-c ] pyridine derivative and preparation method thereof
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
JP2022552324A (en) 2019-10-14 2022-12-15 インサイト・コーポレイション Bicyclic heterocycles as FGFR inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US11897891B2 (en) 2019-12-04 2024-02-13 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
CN115151539A (en) 2019-12-04 2022-10-04 因赛特公司 Derivatives of FGFR inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
MX2022012833A (en) 2020-04-14 2022-11-07 Sunovion Pharmaceuticals Inc (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders.
CA3215903A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220274A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202327600A (en) 2021-10-20 2023-07-16 香港商英科智能有限公司 Methionine adenosyltransferase 2a (mat2a) inhibitors and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311573A (en) * 1970-04-27 1973-03-28 Hisamitsu Pharmaceutical Co Quinazolinedione derivatives
DE2334266A1 (en) * 1972-07-07 1974-01-31 Hisamitsu Pharmaceutical Co PYRIDO SQUARE BRACKET ON 2.3-D SQUARE BRACKET FOR PYRIMIDINE-2,4 (1H, 3H) -DIONE
JPS5758347B2 (en) * 1974-04-03 1982-12-09 Hisamitsu Pharmaceutical Co
JPS5761743B2 (en) * 1974-04-25 1982-12-25 Hisamitsu Pharmaceutical Co
DE2446543A1 (en) * 1974-09-28 1976-04-15 Hoechst Ag Monoazomethine pigments - from 3-hydroxy 4-formylnaphthalic acid or derivs.
DE2614148A1 (en) * 1976-04-02 1977-10-20 Henkel & Cie Gmbh OXIDIZING AGENTS, BLEACHING AGENTS AND DETERGENTS WITH A BLEACH ACTIVATOR CONTENT
IT1228293B (en) * 1989-02-06 1991-06-07 Angeli Inst Spa BENZODERIVATES OF HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN.
AU5813394A (en) * 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
JPH09208543A (en) * 1995-11-29 1997-08-12 Ono Pharmaceut Co Ltd Production of isocyanate derivative and its related compound
WO1997024335A1 (en) * 1995-12-28 1997-07-10 Fuji Chemical Industry Co., Ltd. Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
EP0789020B1 (en) * 1996-02-01 2000-04-12 Sumitomo Chemical Company, Limited Process for producing dioxoquinazolines
JPH09295977A (en) * 1996-04-30 1997-11-18 Terumo Corp Pyridopyrimidine derivative and medicinal composition containing the same
AU6908398A (en) * 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
ES2195397T3 (en) * 1997-10-28 2003-12-01 Warner Lambert Co QUINAZOLIN-2,4-DIONAS REPLACED IN POSITION 7 USEFUL AS ANTIBACTERIAL AGENTS.
ES2304992T3 (en) * 2000-01-24 2008-11-01 Warner-Lambert Company Llc ANTIBACTERIAL AGENTS OF 3-AMINOQUINAZOLIN-2,4-DIONA.
US20030105118A1 (en) * 2000-04-18 2003-06-05 Shuji Masumoto Tricyclic quinazolinediones
JP2002284699A (en) * 2001-03-28 2002-10-03 Sumitomo Pharmaceut Co Ltd Curative for visual cell degenerative disease

Also Published As

Publication number Publication date
GT200200104A (en) 2003-02-11
JP2005501021A (en) 2005-01-13
SV2003001089A (en) 2003-03-18
HN2002000150A (en) 2002-09-13
PE20030272A1 (en) 2003-03-21
WO2002102793A3 (en) 2003-04-10
EP1401830A2 (en) 2004-03-31
WO2002102793A2 (en) 2002-12-27
CA2446963A1 (en) 2002-12-27
DOP2002000422A (en) 2002-12-30
PA8548401A1 (en) 2003-05-14
AU2002302894A1 (en) 2003-01-02
MXPA03009894A (en) 2004-02-17

Similar Documents

Publication Publication Date Title
BR0210028A (en) Antibacterial agents
BR0206955A (en) Cannabinoid Receptor Binders
BR0112030A (en) New compounds that have antibacterial, antifungal or antitumor activity
DE60204452D1 (en) [1,5] pyridine derivatives
BRPI0417771A (en) azabicyclic heterocycles as cannabinoid receptor modulators
BRPI0417820A (en) azabicyclic heterocycles as cannabinoid receptor modulators
BR0205889A (en) Pyrazolopyrimidines as tepapia agents
BRPI0215312B8 (en) compound, use of a compound, pharmaceutical composition, and process for preparing a compound
BR0312464A (en) Tyrosine kinase inhibitors
BRPI0408681A (en) compounds, pharmaceutical compositions, use of a 1,2,3,4-tetrahydroisoquinoline derivative, method for treating or preventing disease, process for the manufacture of pharmaceutical compositions, and use of one or more compounds
ATE264852T1 (en) QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
BR0209129A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds.
BR0212069A (en) Oral antidiabetic agents
BRPI0411017A (en) 3-substituted indoles and derivatives thereof as therapeutic agents
BR0209127A (en) compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
ES2243579T3 (en) DERIVATIVES OF PIRAZOLOPIRIDENO.
BRPI0410913A (en) cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
BR0318278A (en) aminocyclohexyl ether compounds and uses thereof
BR0315139A (en) Tricyclically tetrahydroquinoline antibacterial agents
ES2186550A1 (en) Derivatives of oxazolidinones as antibacterial agents
DE60301339D1 (en) PYRAZOLOPYRIMIDINE AND PYRAZOLOTRIAZINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
BR0209128A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
BR9916807A (en) 5ht1 antagonists for antidepressant therapy
ATE326451T1 (en) QUINAZOLINE DERIVATIVES AND THERAPEUTIC USES THEREOF
AU2002248531A1 (en) Pyrazolopyriadine derivatives

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.